Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Rectal Neoplasms 34Esophageal Neoplasms 19Pancreatic Neoplasms 9Esophageal Squamous Cell Carcinoma 6Stomach Neoplasms 4Colorectal Neoplasms 4Carcinoma, Squamous Cell 3Resectable Esophageal Cancer 2Pathologic Complete Response 2Neoplasms by Site 2Neoplasms 2Gallbladder Neoplasms 2Cholangiocarcinoma 2Carcinoma 2Adenocarcinoma Of Esophagus 2Adenocarcinoma 2Thrombocytopenia 1Rectal Malignant Neoplasms 1Rectal Diseases 1Radiation Injuries 1Postoperative Complications 1Patients With Esophageal Cancer(â…¡-â…¢) 1Pancreatic Cancer Non-resectable 1Neoplasms, Glandular and Epithelial 1Neoplasms, Cystic, Mucinous, and Serous 1Neoplasms by Histologic Type 1Margins of Excision 1Lymphatic Metastasis 1Low Anterior Resection Syndrome 1Locally Advanced Rectal Cancer 1

Interventions

durvalumab 1Observation 1Gemcitabine 1Cisplatin 1Chemoradiotherapy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gallbladder Cancer Unresectable × Chemoradiotherapy × Gastrointestinal × Clear all
NCT05493956 2022-09-09

RACE-GB

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Phase NA Unknown
120 enrolled
GastrointestinalGenitourinary

Gallbladder Cancer Unresectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡